References
Ulger S, Ulger Z, Yildez F, Ozyar E. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med Oncol. 2007;24:91–4.
Garfield DH, Hercbergs A, Davis P. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. JNCI. 2007;99:975–6.
Garfield DH, Hercbergs A, Davis P. Management issues in the hypothyroidism developing in cancer patients treated with sunitinib and other multitargeted tyrosine kinase inhibitors. Nat Clin Pract Oncol. 2007;4:674–5.
Surks ML, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease. JAMA. 2004;291:228–38.
Davis PJ, Davis FB, Lin H-Y, Bergh JJ, Mousa S, Hercbergs A, et al. Cell surface receptor for thyroid hormone and tumor cell proliferation. Expert Rev Endocrin Metab. 2006;1:753–61.
Cody V, Davis PJ, Davis FB. Molecular modeling of the thyroid hormone interactions with avB3 integrin. Steroids. 2007;72:165–70.
Davis PJ, Leonard JL, Davis FB. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol. 2008;29:211-B.
Nelson M, Hercbergs A, Rybicki L, Strome M. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:1041–6.
Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, Cohen BH, et al. Propylthyiouracil-induced chemical hypothyroidism with high dose tamoxifen prolongs survival with increased response rate in recurrent high-grade gliomas. Anticancer Res. 2003;23:617–26.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garfield, D.H., Hercbergs, A. & Davis, P. Management of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med Oncol 25, 474–475 (2008). https://doi.org/10.1007/s12032-008-9068-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9068-9